---
document_datetime: 2025-11-17 13:30:39
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/voxzogo-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: voxzogo-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.633197
conversion_datetime: 2025-12-25 03:45:23.905326
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Voxzogo

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                       | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|---------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IB /  | B.II.g.5 Implementation of changes foreseen | 17/11/2025                          |                                             | SmPC                             |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000300615                        | in an approved change management protocol - B.II.g.5.c Implementation of a change for a biological/immunological medicinal product - Accepted                                                                                                                                                                                                                                                                                                      |            |     |      |
|------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|
| Variation type IB / EMA/VR/0000280939    | This was an application for a group of variations. B.II.d.2 Change in test procedure for the finished product - B.II.d.2.d Other changes to a test procedure (including replacement or addition) - Accepted B.III.2 Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - B.III.2.b Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State - Accepted | 17/07/2025 | N/A |      |
| Variation type IB / EMA/VR/0000268773    | B.II.f.1.b Extension of the shelf life of the finished product - B.II.f.1.b.5 Extension of the shelf-life of a biological/ immunological medicinal product in accordance with an approved stability protocol - Accepted                                                                                                                                                                                                                            | 27/05/2025 |     | SmPC |
| Variation type IA_IN / EMA/VR/0000246741 | B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished                                                                                                                                                                                                                                                                                                                              | 30/01/2025 | N/A |      |

<div style=\"page-break-after: always\"></div>

| product - B.II.b.1.a Secondary packaging site - Accepted   |
|------------------------------------------------------------|